Company Update: CVS Caremark Corporation (NYSE:CVS) – CVS Health’s MinuteClinic Marks Decade of Accreditation from The Joint Commission With Latest Evaluation

[PR Newswire] – WOONSOCKET, R.I., Jan. 14, 2016 /PRNewswire/ — Ten years after becoming the first national retail clinic provider to be accredited by The Joint Commission (then JCAHO), MinuteClinic, the walk-in medical clinic of CVS Health, has achieved its third consecutive reaccreditation from the national health care evaluation and certifying agency. The Joint Commission’s Gold Seal of Approval™ demonstrates MinuteClinic’s compliance with the organization’s national standards for ambulatory health care quality and safety. Valid for up to a three-year period, The Joint Commission accreditation applies to MinuteClinic’s 1,050 locations inside select CVS/pharmacy stores in 33 states and the District of Columbia. Read more on this. CVS Health Corporation (CVS) , valued at $106.24B, started trading this morning at $94.11. Today’s price range has been between $94.11 and $96.34 per share and has traded between $81.37 and $113.65 over the past 12 months. CVS shares are currently priced at 18.20x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s 10.49x earnings multiple for the same period. And for passive income investors, the company pays shareholders $1.70 per share annually in dividends, yielding 1.82%. According to a consensus of 21 analysts, the earnings estimate of $1.50 per share would be $0.29 better than the year-ago quarter and a $0.00 sequential decrease. The full-year EPS estimate is $5.17 which would be a $0.66 improvement than last year’s full-year earnings. The quarterly earnings estimate is predicated on a consensus revenue forecast of $40.97 Billion. If reported, that would be a 10.55% increase over the year-ago quarter. In terms of ratings, Goldman downgraded CVS from Buy to Neutral (Dec 17, 2015). Previously, Oppenheimer Initiated CVS at to Outperform. When considering if perhaps the stock is under or overvalued, the average price target is $116.19, which is 23.46% above where the stock opened this morning. See more in (NYSE:CVS) Similar Articles: Stock Update: CVS Caremark Corporation (NYSE:CVS) – CVS Health’s MinuteClinic Surpasses Milestone of 1,000 Clinics Across the U.S. Market Update: CVS Caremark Corporation (NYSE:CVS) – CVS Health Corporation Commences Exchange Offers and Consent Solicitations Company Update: CVS Caremark Corporation (NYSE:CVS) – CVS Health Research Institute Analysis Shows High Patient Satisfaction with MinuteClinic Telehealth Visits